Merit Medical Systems, Inc. (MMSI)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Merit Medical Systems, Inc. To Contact The Firm 

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ:MMSI) of the February 3, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. 

If you invested in Merit Medical stock or options between February 26, 2019 and October 30, 2019 and would like to discuss your legal rights, please fill out the form below. There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to  

The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased Merit Medical common stock between February 26, 2019 and October 30, 2019 (the “Class Period”).  The case, Bucks County Employees Retirement Fund v. Merit Medical Systems, Inc. et al., No. 19-cv-02326 was filed on December 3, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, were causing operational disruptions and reduced sales and were months behind schedule; (2) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during FY19; and (3) in light of the foregoing, the Company’s reported financial guidance for FY19 and FY20 was made without a reasonable basis

On July 26, 2019, Morningstar issued an analyst report, titled “Merit’s 2Q Miss Poised to Reset Investor Expectations; Reiterate Our Overvalued Call,” which noted that while the FY20 growth forecast was maintained, it was based on a smaller base and thus was actually a reduction.

On this news, the Company's stock price fell from $54.84 per share on July 25, 2019 to $41.00 per share on July 26, 2019: a $13.84 or 25.24% drop.

Then, on October 30, 2019, Piper Jaffray issued an analyst report on Merit, titled “Another Shoe Drops Here in Q3; Sticking with OW,” which discussed the “Disappointing Q3 Results,” which were primarily attributable to the Company’s acquisitions, and reduced its price target to $30.00 from $40.00.

On this news, the Company's stock price fell from $29.11 per share on October 30, 2019 to $20.66 per share on October 31, 2019: an $8.45 or 20.03% drop

Contact us

Merit Medical Systems, Inc. (MMSI)

Loading captcha, please wait...

* The submission of this form does not create an attorney-client relationship.


Filed on 12/09/2019


Lead Plaintiff Deadline 02/03/2020


685 Third Avenue 26th Floor

10017 New York, New York

Phone (212) 983-9330

Fax (212) 983-9331


Richard W. Gonnello Phone (212) 983-9330 Fax (212) 983-9331

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885


3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612


3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania